Health TrialsbyHealthPanel

Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

ConditionsIliopsoas Nerve BlockFemoral Nerve BlockHip Fracture Surgeries
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAin Shams University

About this trial

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 18 to 65 years.

Both sexes.

American Society of Anesthesiologists (ASA) physical status I and II.

Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.

Disqualifiers

Refusal to participate.

Coagulopathy.

Patients with a history of drug allergies to study drugs.

Inability to cooperate.

Trial population

This prospective, single-blind cohort study will be conducted on 80 patients scheduled for elective surgical correction of hip fracture after obtaining approval from the Research Ethical Committee of Ain Shams University. It will be conducted in the assembled operation rooms in Ain Shams University Hospitals.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Iliopsoas nerve block

    Drug

    Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

  • Femoral nerve block

    Drug

    Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Iliopsoas nerve block group1 intervention
Group B: Femoral nerve block group1 intervention

Trial outcomes

Primary outcomes

1

Degree of pain

Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed upon arrival at the post-anesthesia care unit (PACU) and at 2, 4, 6,12, 24 post-surgery.

Time frame
24 hours postoperatively

Secondary outcomes

1

Total opioids consumption

Intravenous pethidine (25mg) will be given to be repeated after 15 min if no response up to a maximum dose of 50 mg In case of moderate to sever pain.

Time frame
24 hours postoperatively
2

Assessment of quadriceps strength

The quadriceps strength will be assessed using the manual muscle testing (MMT) grade (0-5; 0: no muscle contraction, 1: muscle contraction present but unable move joint, 2: able to move joint but not resist gravity, 3: able to resist gravity but not bear substantial resistance, 4: able to resist some level of substantial resistance, 5: able to resist full resistance).

Time frame
24 hours postoperatively
3

Time of ambulation

Time of ambulation will be recorded from the end of surgery till walking or moving from place to place

Time frame
24 hours postoperatively
4

Patients' satisfaction

Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied)

Time frame
24 hours postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov
Apply now